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Abstract
Background:  An increased oxidative level and decreased anti-
oxidant activities in the blood of preeclamptic women have been 
reported by us and other workers. The present study was aimed to 
evaluate oxidative stress in infants born to preeclamptic mothers, 
and to examine whether cord blood with oxygen radical disease 
had different total enzymatic antioxidant status than those without 
preeclampsia.
Methods:  The present study consisted of 23 normotensive (served 
as control) and 23 preeclamptic mothers. We compared their oxi-
dative and anti-oxidative system in maternal and cord blood of 
pair-matched mother and neonate. Their blood malondialdehyde 
(MDA), antioxidant enzymes were determined and compared to 
evaluate if pro-oxidative status of preeclampsia differs from the 
status in cord blood of pair-matched neonate.
Results:  The MDA content in preeclamptic maternal plasma was 
significantly high (p < 0.001) compared to that of control. Inter-
estingly, its content in preeclamptic cord blood was significantly 
low (p < 0.001) compared to their pair-matched maternal blood. 
Superoxide dismutase (SOD) activity was 8.7% higher in cord as 
compared  to  pair-matched  normotensive  maternal  blood  which 
was significant (p = 0.01) whereas in preeclamptic cord the level 
decreased significantly (p = 0.011) in comparison to pair-matched 
preeclamptic maternal. Glutathione peroxidase (GPx) was 16.4% 
higher  in  normotensive  cord  compared  to  maternal  blood,  and 
7% low in preeclamptic cord compared to pair-matched maternal 
blood. The increase was significant (P = 0.011) in normotensive 
cord whereas in preeclamptic cord the decrease was insignificant 
(p=0.06). Contrary to earlier reports on catalase activity, our results 
showed 20.97% elevation in normotensive and 16.12% increase in 
the preeclamptic cord blood compared to their pair-matched mater-
nal blood. This change was significant with p = 0.01 and p = 0.017 
in control and preeclamptic group respectively.
Conclusions:  Our results showed the significantly low MDA con-
tents in the pair-matched cord blood and the activities of SOD, 
GPx and Catalase mentioned above, we conclude that the oxidative 
stress status is low in the blood of neonates born to preeclamptic 
mothers. Further studies are needed to explore strategies so that 
the normal levels of antioxidant vitamins are maintained to combat 
preeclampsia in women at high risk.
Keywords:  Maternal; Cord blood; Malondialdehyde; Antioxidant 
enzymes; Glutathione peroxidase; Glutathione reductase; Superox-
ide dismutase; Catalase
Introduction
  Cord blood antioxidant capacity is the result of overall 
intrauterine experience, making the intrauterine period cru-
cial of the fetal development, which is the result of complex 
interaction  among  the  three  components  of  maternal-pla-
cental-fetal unit. Babies born at term to preeclamptic moth-
ers provide a unique opportunity to have an insight into the 
mechanism and implications of the fetal development, sec-
ondary to intrauterine redox-status.   
 Our aim was to assess the relationship between lipid 
peroxidation and maternal/cord blood enzymatic antioxidant 
capacity and to examine whether cord blood with oxygen 
radical disease had different total enzymatic antioxidant sta-
tus than those without preeclampsia (PE), a disorder of preg-
nancy  characterized  by  pregnancy-induced  hypertension 
(≥ 140 mmHg systolic and/or ≥ 90 mmHg diastolic blood 
pressure), new-onset proteinuria (≥ 300mg protein/day), and 
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edema occurring in the second half of pregnancy.
  Oxidative stress has been implicated in the pathophysi-
ology of PE because it damages the maternal vascular endo-
thelium, and there is indisputable evidence that the normal 
role of this cell layer is severely compromised in PE [1]. 
With cumulative evidences in recent years, we have recently 
shown that a biochemical imbalance in preeclampsia occurs 
with an increase of oxidative stress and lipoperoxidation and, 
at the same time, a deficient antioxidant protection [2, 3, 4].  
  Significant elevation of malondialdehyde (MDA) lev-
els in cord blood of pair-matched preeclamptic mother have 
been reported [5, 6] whereas others have concluded decline 
in its level [7] or no significant change [8, 9], but Karabu-
lut et al [10] inferred elevation of MDA levels both in cord 
and mother during preeclamptic development compared to 
normal pregnancy. Similarly, contradictions exist about the 
level of antioxidant enzymes in the cord blood of preeclamp-
tic mothers. 
  Significantly decreased enzymatic activities of super-
oxide dismutase (SOD), glutathione peroxidase (GPx), and 
catalase (CAT) have been reported [6, 7, 11, 12] in cord 
blood of the full term newborns of preeclamptic mothers as 
compared  to  their  pair-matched  maternal  blood.  Contrary 
findings of increased SOD activity [8] and no change in the 
activity of GPx in the cord blood have also been reported 
[8, 9].  
  Inconsistency in these reports has led us to take up the 
present study to assess the relationship between lipoperoxi-
dation and pair-matched cord blood antioxidant enzymatic 
activities; and to examine whether the maternal and cord 
plasma concentrations of MDA and these enzymes levels 
differ between preeclamptic and healthy pregnant women. 
Further, we aimed to investigate whether a variation or cor-
relation in oxidant and antioxidant levels between maternal 
blood and fetal cord blood exists consequent to their antioxi-
dant enzymes activities.
 
Materials and Methods
 
Chemicals   
    
  NADPH,  Oxidized  glutathione  (GSSG),  Glutathione 
Reductase  (GRx),  EDTA,  Thiobarbituric  acid  (TBA)  and 
butylated hydroxytoluene (BHT) were from Sigma Chemi-
cal Company (St. Louis, MO, USA). Other chemicals of ana-
lytical grade were obtained from either E. Merck (Mumbai, 
India), BDH or SISCO Chemicals (Mumbai, India).
 
Subjects
  In India, pregnant women are encouraged to book and 
to attend regular antenatal check ups. Standard antenatal care 
is defined as monthly visits up to 28 weeks; fortnightly un-
til 34 weeks, and weekly visits thereafter. The present study 
was carried out with the prior approval of local ethical com-
mittee. The patients in our study included normal pregnant 
women with normal blood pressure, and preeclamptic wom-
en admitted to our hospital who had been or not under regu-
lar care and also those who were referred from private sec-
tors or primary health centers. Twenty three normal pregnant 
women who served as control, and 23 severely preeclamptic 
patients with singleton pregnancies were selected.   
  Control  group  had  two  and  preeclamptic  group  had 
five caesarian sections, because of prolonged labor.  They 
gave their consent in writing and the objectives of the study 
were fully explained to them in detail prior to taking consent. 
Height and weight of the subjects were measured to calculate 
their body mass index (BMI). Clinical examination and his-
tory taking excluded women addicted to tobacco, patients 
with diabetes, ischemic heart disease, a history of stroke, 
kidney disorders or other conditions of known free radical 
etiology. The criteria for dividing women into normal and 
severely preeclamptic groups were set at a blood pressure of 
≥ 160/110 mmHg with proteinuria, over 0.3 g protein/day, 
and edema.  
 
Sample Collection      
  Blood samples were collected from the mothers at de-
livery, cord blood was obtained immediately post partum 
from the umbilical vein after clamping of the cord by la-
bor ward staff. In each case, 10 ml blood were drawn into 
a sodium heparin vacutainer tube for separating plasma and 
stored at 4 oC until processed. Maternal and umbilical cord 
blood samples were handled identically; all samples were 
processed within 20 hours of sampling.   
 The blood samples were centrifuged at 1000 g for 15 
min at 4°C, the isolated red cells were washed 4 - 5 times 
with 0.154 M NaCl to remove plasma and buffy coat. After 
the final wash, required packed red cells were lysed by hypo-
tonic shock and different dilutions were used as hemolysates.
 
Estimation of lipid peroxidation        
  Lipid peroxidation was quantified following the method 
of Jain et al [13].  Packed red cells (0.2 ml) were used for the 
quantification of malondialdehyde (MDA) as thiobarbituric 
acid reactive substances (TBARS). Aliquots of 0.2 ml were 
mixed thoroughly with 0.8 ml of phosphate-buffered saline 
(8.1 g NaCl, 2.302 g Na2HPO4, and 0.194 g NaH2PO4/L,  pH 
7.4) and 25 μl of butylatedhydroxytoulene (BHT, 88 mg/10 
ml absolute alcohol) solution. After adding 0.5 ml of 30% 
trichloroacetic acid, the samples were vortexed and allowed 
to stand in ice for at least 2 hrs, and then centrifuged at 2000 
g at 25 oC for 15 min. One ml of supernatant was mixed with 
75 μl of 0.1M EDTA and 250 μl of 1% thiobarbituric acid in 
0.05M NaOH and placed on boiling water for 15 min. After 
150                                                                                                                                                 151J Clin Med Res  •  2009;1(3):150-157           Antioxidant Enzymes in Preeclamptic Cord Blood
Articles © The authors, Journal compilation © J Clin Med Res and Elmer Press™, www.jocmr.org
cooling to room temperature, absorbance was measured at 
532 nm and 600 nm. Absorbance at 600 nm was subtracted 
from absorbance at 532 nm for evaluation of MDA. BHT, an 
antioxidant, was added to prevent MDA formation during 
assay, which could result in falsely elevated TBA reactivity. 
The addition of BHT to standard MDA did not affect the col-
or development with TBA. MDA contents were expressed 
as nmol/gHb.
 
Assay of GPx (EC 1.11.1.9) activity
 GPx activity was measured spectrophotometrically fol-
lowing the method of Paglia and Valentine [14]. The lysate 
was mixed with an equal volume of Drabkin’s reagent to 
convert  all  hemoglobin  to  the  stable  cyanmethemoglobin 
form. Exactly 0.1 ml of this mixture was added to 2.58 ml, 
50 mM phosphate, pH 7.0 containing 5 mM EDTA. The fol-
lowing solutions were then added in turn: 100 μl, 8.4 mM 
NADPH, 10 μl GRx (0.3 U/ml), 10 μl, 1.125 M sodium azide 
and 100 μl, 150 mM GSH. The reaction mixture was allowed 
to equilibrate at 20 oC in the cuvette of the spectrophotom-
eter. The enzymatic reaction was initiated by addition of 100 
μl, 2.2 mM H2O2. The conversion of NADPH to NADP was 
followed by continuous monitoring of the change in absor-
bance of the system at 340 nm between 2 and 4 minutes after 
initiation of the reaction. One unit of GPx was considered 
to be the amount necessary to oxidize 1 μmol NADPH/min. 
Activity is expressed as U/gHb.
 
Assay of SOD (EC 1.15.1.1) activity       
  SOD activity was measured according to the method of 
Beutler [15]. Briefly, the reaction is dependent on the pres-
ence of superoxide anions that cause the oxidation of pyro-
gallol SOD which inhibits the auto-oxidation of pyrogallol, 
by catalyzing the breakdown of superoxide. The inhibition of 
pyrogallol oxidation by SOD was monitored and the amount 
of enzyme producing 50% inhibition was defined as one unit 
of enzyme activity. The assay mixture contained 1 M Tris 
HCl-5 mM EDTA buffer, pH 8.0, and 10 mM pyrogallol. The 
inhibition of pyrogallol oxidation by SOD was monitored at 
420 nm on a recorder giving full-scale reading of 1 OD, the 
activity of enzyme was evaluated and expressed as U/gHb.
 
Assay of Catalase (EC 1.11.1.6) activity       
  Catalase  decomposes  the  H2O2 and  forms  water  and 
molecular oxygen. H2O2 absorbs maximum light at 240 nm. 
When H2O2 is decomposed by catalase, the absorbance de-
creases. Determination of catalase activity was assayed by 
monitoring the rate of decomposition of H2O2 spectrophoto-
metrically at 240 nm following the procedure of Aebi [16]. 
The assay mixture contained 2.0 ml of enzyme or homoly-
sate and 1 ml, 30 mM H2O2 at 20 oC with the final volume 
of  3.0 ml against a blank containing 1 ml, 50 mM phosphate 
buffer, pH 7.0, instead of substrate and 2 ml enzyme solu-
tion or hemolysate. The reaction was started by the addition 
of H2O2, 0.9 ml of 1 M Tris, 5 mM EDTA buffer, pH 7.0 
and 0.1 ml of the sample. The decrease in absorbance was 
measured with a recorder at an interval of 30 seconds for 3 
minutes. The value of absorbance of the reference was sub-
tracted from that of the test cuvette before units of activity 
                     
 
Parameters                                                     Normotensive               Severely                                   P*-value 
ue                                                                                                                                                                                                    
                                                                         control group                preeclamptic group 
up                                                                                
Number of maternal/neonatal pairs                  23                                  23
Maternal age (years)                                        29.1 ± 6.9                      26.8 ± 7.2                                  0.275     
BMI at delivery (kg/m2 )                                  22.1 ± 2.5                      21.4 ± 2.8                                  0.376      
Gestational age (weeks)                                   33.8 ± 3.9                      32.2 ± 4.8                                  0.221    
BP at delivery, systolic (mm/Hg)                     109.8 ± 12.9                  164.5 ± 13.6                              < 0.0001    
 
BP at delivery, diastolic (mm/Hg)                    65.6 ± 11.4                    111.4 ± 14.2                              < 0.0001     
Pulse rate (beats/min)                                       71.4 ± 1.6                      70.8 ± 2.4                                  0.324      
Proteinuria (g/day)                                           Nil                                  1.24 ± 0.86                                  /     
Edema                                                              Nil                                   ++ in all cases                             /
Table 1. Demographic and clinical characteristics of normotensive (control) and severe preeclamptic subjects
Values are expressed as mean ± SD; BMI- body mass index; BP- blood pressure,  P*= Two-Samples t-test probability
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were calculated. The activity of catalase was evaluated and 
expressed as kU/gHb.
 
Assay of GRx (EC 1.8.1.7) activity
  The main reagent was prepared by combining 18 ml of 
KH2PO4 buffer 139 mM, 0.76 mM EDTA, pH 7.4, and 2 ml 
of 2.5 mM NADPH. The sample (20 μl of 1: 20 hemolysate 
+ 20 μL of KH2PO4 buffer), 220 μl of the main reagent and 5 
μ of FAD 0. 315 mM + 10 μl of KH2PO4 buffer were added 
to the cuvette and the absorbance at 340 nm was monitored 
for 200s (step A). Then 30 μl of GSSG 22mM + 10 μl of 
KH2PO4 buffer were added to start the reaction and the ab-
sorbance was followed for 175 s (step B). The final reaction 
volume was 315 μl. The difference in absorbance per minute 
between steps B and A was used to calculate the enzyme 
activity. The unit is μmol of NADPH oxidized /min and the 
GRx activity is evaluated and expressed as U/gHb [17].
 
Hemoglobin estimation   
       
  The method of Tentori and Salvati [18] was employed 
for  hemoglobin  estimation.  Hemoglobin  content  of  the 
sample was measured using cyanmethemoglobin method by 
mixing 20 μl of blood and 5 ml of (1: 251 diluted) ferricya-
nide reagent, K3Fe(CN)6, 200 mg; KCN  50 mg; K2HPO4 140 
mg; appropriate amount of detergent Triton X-100 dissolved 
and raised to one  liter, pH 7.4, and allowing to stand for at 
least 3 min. Afterwards, absorbance was read at 540 nm us-
ing water as blank.               
 
Statistical analysis 
  SPSS version 15.0 for Windows (SPSS Inc., Chicago, 
IL, USA) software package was used to analyze the data and 
to obtain the box-plots for various parameters. The results 
were  statistically  analyzed  using  paired-samples  t-test  to 
compare both maternal/cord blood of normotensive pregnant 
and preeclamptic patients groups. The t-test statistical sig-
nificance was set at P ≤ 0.05. Values were expressed as Mean 
± Standard Deviation.
 
Results
 We evaluated the quantum of enzymatic antioxidant 
defense in maternal and cord blood of two groups of pair-
matched maternal and neonates. Control group consisted of 
23 uncomplicated, normotensive-pregnancies and the second 
group included 23 severely preeclamptic patients, all single-
ton pregnancies. Control group had two, whereas preeclamp-
tic group had four caesarian sections, because of prolonged 
labor. The clinical characteristics of these groups are shown 
in Table 1.  The activities of   SOD, GPx, GRx and Catalase 
are summarized as mean ± standard deviation in Table 2.   
  The MDA contents varied from 4.12 to 12.79 nmol/
gHb in normotensive maternal and 3.89 to 11.06 nmol/gHb 
in normotensive cord, whereas it varied from 8.75 to 15.19 
nmol/gHb in preeclamptic maternal and 6.75 to10.34 nmol/
gHb in preeclamptic cord. Their mean values are mentioned 
in Table 2. The MDA content in preeclamptic maternal blood 
was found to be 32.8% higher than that of control. There was 
             
Parameters                         Normotensive   maternal         Normotensive   cord           Preeclamptic   maternal           Preeclamptic   cord              
                                             (n = 23)                                      (n = 23)                                (n = 23)                                       (n = 23)              
 Malondialdehyde (MDA)   9.02 ± 2.36                                 7.36 ± 1.62                           11.98  ± 1.83                               8.02 ± 1.05
 (nmol/gHb)                         (Cl*: 8.008 to 10.04)                   (Cl*: 6.66 to 8.06)                (Cl*: 11.19 to 12.77)                   (Cl*: 7.56 to 8.47) 
Superoxide dismutase         1135.95 ± 100.28                       1235.17 ± 119.07                  921.92 ± 117.54                          842.16 ± 81.24
(U/gHb)                               (Cl*: 1092.58 to 1179.32)          (Cl*: 1183.68 to 1286.66)     (Cl*: 871.09 to 972.74)                (Cl*: 807.03 to 877.29)
Glutathione peroxidase       15.21 ±  3.04                              17.71 ±  2.27                        13.92 ±  1.36                                12.95 ±  1.89 
(U/gHb)                               (Cl*: 13.9 to 16.53)                    (Cl*: 16.73 to 18.69)             (Cl*: 13.33 to 14.51)                    (Cl*: 12.14 to 13.77)
Glutathione reductase          11.24 ± 3.03                              10.98 ± 2.90                          8.98 ± 2.44                                  8.85 ± 2.46   
(U/gHb)                               (Cl*: 9.93 to 12.54)                    (Cl*: 9.97 to 12.23)               (Cl*: 7.93 to 10.04)                      (Cl*: 7.79 to 9.92)
Catalase (kU/gHb)               98.21 ± 21.17                            118.80 ± 25.81                      124.70 ± 17.48                            144.8 ± 34.99  
                                             (Cl*: 89.05 to 107.36)                (Cl*: 107.64 to 129.96)         (Cl*: 117.14 to 132.26)                (Cl*: 129.67 to 159.93) 
    
Table 2. Concentrations of malondialdehyde and activities of various antioxidant enzymes in pair-matched normotensive 
(control) and severely preeclamptic maternal and cord blood
Values are expressed as mean ± SD; Cl* = 95%  Confidence Interval for mean
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no significant difference (p = 0.021) between control mater-
nal and cord blood levels. The MDA content in preeclamptic 
maternal plasma was significantly high (p < 0.001) compared 
to that of control. However, its content in preeclamptic cord 
blood compared to their pair-matched maternal blood was 
significantly low (p < 0.001). The variations in its contents 
in pair-matched normotensive and preeclamptic maternal as 
well as cord blood have been shown in Figure 1. 
  The  activity  of  superoxide  dismutase  ranged  from 
980.73 to 1375.65 U/gHb, 1055.59 to 1465.97 U/gHb, 702.05 
to 1141.71 U/gHb and 655.69 to 970.12 U/gHb in normoten-
sive maternal, pair-matched cord, preeclamptic maternal and 
pair-matched cord, respectively, with the mean values given 
in Table 2. It was found to be 8.7% higher in cord as com-
pared to pair-matched normotensive maternal blood which 
was significant (p = 0.01), whereas in preeclamptic cord the 
level decreased significantly (p = 0.011) in comparison to 
pair-matched  preeclamptic  maternal. The  variations  in  its 
levels in pair-matched normotensive and preeclamptic ma-
ternal as well as cord blood are shown in Figure 2. 
  Glutathione peroxidase (GPx) was found to vary from 
9.94 to 21.02 U/gHb, 14.15 to 22.14 U/gHb, 10.75 to 15.80 
U/gHb,  10.08  to  16.28  U/gHb  in  normotensive  maternal, 
pair-matched  cord,  preeclamptic  maternal,  pair-matched 
cord, respectively, with their mean values mentioned in Ta-
ble 2. It was 16.4% higher in normotensive cord compared to 
maternal blood and 7% low in preeclamptic cord compared 
to pair-matched maternal blood. The increase was significant 
(P = 0.011) in normotensive cord, whereas in preeclamptic 
cord the decrease was insignificant (p = 0.06). The variations 
in activities in pair-matched normotensive and preeclamptic 
maternal as well as cord plasma are shown in Figure 3.
  In control group, the glutathione reductase (GRx) activ-
ity ranged from 5.84 to 17.28 U/gHb in maternal blood and 
4.24 to 14.89 U/gHb in cord blood, whereas in preeclamptic 
group it varied from 4.55 to 12.18 U/gHb in maternal and 
Figure 1. MDA concentrations in pair-matched normotensive and 
preeclamptic maternal and cord blood.
Figure 2. SOD activities in pair-matched normotensive and pre-
eclamptic maternal and cord blood.
Figure 3. GPx activities in pair-matched normotensive and pre-
eclamptic maternal and cord blood.
Figure 4. GRx activities in pair-matched normotensive and pre-
eclamptic maternal and cord blood.
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4.65 to 14.20 in cord blood with the mean values shown in 
Table 2. The box-plots of these values are shown in Figure 4, 
which represent these variations clearly with no significant 
difference between maternal and pair-matched cord blood in 
control (p = 0.765), and preeclamptic group (p = 0.863). But, 
the difference in the mean values of maternal and cord blood 
of both groups was significant (p = 0.015 and p = 0.008, 
respectively).  There  was  20.1%  decrease  in  preeclamptic 
maternal blood and 19.4% decrease in the GRx activity in 
preeclamptic cord blood when compared to their respective 
normotensive maternal and cord blood.
  Catalase activity was found elevated in the cord blood 
of  both  the  groups.  There  was  20.97%  elevation  in  nor-
motensive  and  16.12%  increase  in  the  preeclamptic  cord 
blood compared to their pair-matched maternal blood. This 
change was significant with p = 0.01 and  p= 0.017 in con-
trol and preeclamptic group respectively. These changes are 
represented in the form of box plots in Figure 5. The activ-
ity ranged from 69.99 to 146.54, 61.43 to 154.73, 85.46 to 
157.23 and 74.25 to 189.58 in normotensive maternal, cord, 
preeclamptic maternal and cord blood, respectively, with the 
mean values shown in Table 2.
Discussion
  
 The present study investigated maternal plasma enzy-
matic antioxidant levels during normal and complicated pre-
eclamptic pregnancies and their relationships with neonatal 
antioxidant  levels.  Cumulative  evidences  in  recent  years 
show that a biochemical imbalance in preeclampsia occurs 
with an increase of oxidative stress and a deficient antioxi-
dant protection [2, 3, 4].  Indeed, free radicals released from 
the poorly perfused fetoplacental unit initiate lipid peroxida-
tion by attacking polyunsaturated fatty acids in cell mem-
branes, converting them to lipid peroxides and to a variety 
of secondary metabolites. Uncontrolled peroxidation alters 
membrane fluidity and permeability, therefore the lipid per-
oxides and their secondary metabolites, such as malondial-
dehyde (MDA, a good indicator of oxidant forces formed at 
a primary site), are then transported through the circulation 
by lipoproteins, causing damage at distant tissues.
  In the preeclamptic pregnancy, the oxidant/antioxidant 
balance of normal pregnancy is skewed to favor oxidants at 
the expense of antioxidants. Antioxidant defense systems in-
clude the chain-breaking antioxidants, such as vitamin C and 
vitamin E, and the antioxidant enzymes. Lipid-phase chain-
breaking antioxidants, the most important of which is prob-
ably vitamin E [19], scavenge radicals in membranes and 
lipoprotein particles and are central to the prevention of lipid 
peroxidation.  Aqueous-phase  chain-breaking  antioxidants 
directly scavenge radicals present in the aqueous compart-
ment. Vitamin C or ascorbate is the most important aqueous 
phase chain-breaking antioxidant [20]. It is well established 
that there is synergy between vitamins C and E. This interac-
tion between vitamin C and vitamin E has been confirmed in 
vivo by workers [21], who have reported that supplementa-
tion of healthy adults with ascorbic acid increases ascorbic 
acid and lipid-standardized alpha-tocopherol levels in plas-
ma, and that supplementation with alpha-tocopherol is as-
sociated with increased plasma ascorbic acid concentration, 
as well as improved vitamin E status. Our recent reports [22] 
showed significantly high vitamin C levels in the cords of 
both normotensive as well as preeclamptic mothers, which 
showed retention of comparatively elevated antioxidant ca-
pacity in the cords.
  Our  results  showed  32.8%  higher  MDA  contents  in 
preeclamptics compared to normotensive maternal plasma. 
Earlier, it has been reported [23] that preeclamptic placenta 
contains higher MDA than those from normal pregnancies. 
Our previous reports [3, 4] have shown significant elevation 
of MDA or TBARS during the development of PE. This may 
result in a greater potential for endothelial damage ultimately 
leading to enhanced diastolic pressure [20] which further ag-
gravates the condition of preeclamptic patients. Enhanced 
ROS in turn can oxidize many other important biomolecules 
including  erythrocyte  membrane  phospholipids.  The  in-
teresting finding of the present study is 33.1% lower level 
of MDA concentrations in the cord plasma as compared to 
maternal plasma in preeclamptics. Our present findings on 
MDA concentrations are consistent with those of Orhan et 
al [7].  
 Superpxode dismutase (SOD), Catalase, GRx, and glu-
tathione peroxidase (GPx) are important parts of the defense 
system. SOD protects and revitalizes cells and reduces the 
rate of cell destruction. It neutralizes some of the most dan-
gerous free radicals, the superoxide radicals, before they can 
wreak havoc on the body. Superoxide generation also perpet-
uates oxidative stress and lipid peroxidation through the oxi-
dation of mitochondrial iron-sulphur clusters such as aconi-
Figure 5. Catalase activities in pair-matched normotensive and 
preeclamptic maternal and cord blood.
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tase, which subsequently stimulate membrane phopholipid 
peroxidation by alkoxyl radicals [24]. SOD is an important 
antioxidant enzyme having an antitoxic effect against super 
oxide anion and catalyses the reaction in which superoxide 
radicals are converted to H2O2 and O2. It decreases superox-
ide anion concentration in the vascular cell [25], a mecha-
nism  that  could  counteract  the  development  of  hyperten-
sion. In normotensive cord, SOD increased 8.7% compared 
to maternal blood, but in preeclamptic cord it decreased to 
8.65% as compared to their pair-matched maternal blood, 
and both the alterations were significant, p = 0.01 and p = 
0.011, respectively. Our results pertaining to SOD activity in 
preeclamptic cord blood are in harmony with the reports of 
others [6, 7, 11, 12]. 
  The principal function of GPx is to protect against dam-
age from the endogenously produced hydroxyperoxides and 
to catalyze the reduction of hydroxyperoxides by glutathi-
one. Catalase promotes the conversion of hydrogen perox-
ide, a powerful and potentially harmful oxidizing agent, to 
water and molecular oxygen. It also uses H2O2 to oxidize 
toxins such as phenols, formic acid, formaldehyde and al-
cohols.  Catalase,  along-with  SOD  and  GPx  controls  the 
levels of oxygen-derived free radicals in cells. During our 
present study the alteration in GPx activities was not sig-
nificant (p = 0.06) between preeclamptic maternal and cord 
blood. However, in control group there was 16.4% increase 
in GPx activity in cord blood as compared to maternal group 
which was significant (p = 0.011). There was no significant 
change in the activity of GRx between maternal blood and 
pair-matched cord blood of control and preeclamptic group 
(p = 0.765 and p = 0.863, respectively).  Interestingly, the 
activity of catalase was found to enhance very significantly 
in cord blood of  normotensive and preeclamptic groups as 
compared to their pair-matched maternal blood (21% and 
16% increase respectively ), which show its compensatory 
regulation in response to increased oxidative stress. The sig-
nificant  elevation  in  preeclamptic  catalase  activity  shows 
the protective effect of this enzyme, which protects the cells 
from the accumulation of H2O2 by dismutating it to form wa-
ter and oxygen by using it as an oxidant in which it works as 
a peroxidase [26].
 In conclusion, we hypothesize the elevated oxidative 
stress in preeclampsia, our results showed decreased SOD, 
GRx and GPx activities, which failed to control higher oxy-
gen free radical produced therein, this is consistent with our 
previous report [3]. However, no significant decrease was 
found in the activities of GPx and GRx in their pair-matched 
cord blood. Increased activity of catalase may be a compen-
satory regulation in response to increased oxidative stress. 
Increased catalase activity in the pair-matched cord blood 
could be interpreted as an effort to counteract the overpro-
duction of reactive oxygen species and provide a relief to 
enhanced oxidative damage in preeclampsia. From our find-
ings of significantly low MDA contents in the pair-matched 
cord blood, we hypothesize that antioxidant capacity of cord 
blood is sufficient and placental barrier is adequate, to shield 
the fetus from the oxidative injury due to higher oxidative 
stress of preeclamptic mother. Thus, we conclude that the 
oxidative stress status is low in the blood of neonates com-
pared to its level in the pair-matched preeclamptic mothers. 
Further studies are needed to explore strategies so that the 
normal levels of antioxidant vitamins are maintained to com-
bat preeclampsia in women at high risk.
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